Invited commentary: Evaluating vaccination programs using genetic sequence data

American Journal of Epidemiology

Volumn 170, Issue 12, 2009, Pages 1464-1466

  Halloran, M Elizabeth ^a,b   Holmes, Edward C ^c,d  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Communicable diseases; Disease notification; Disease transmission, infectious; Genetic variation; Hepatitis B virus; Molecular sequence data; Vaccination

Indexed keywords

HEPATITIS B VACCINE;

DEMOGRAPHY; GENE SEQUENCE; GENETIC VARIABILITY; GENOMICS; HEPATITIS B; HUMAN; MALE HOMOSEXUAL; MORBIDITY; NOTE; PHYLOGENY; POPULATION GROWTH; POPULATION SIZE; SAMPLING; VACCINATION;

ACUTE DISEASE; BASE SEQUENCE; BAYES THEOREM; DISEASE NOTIFICATION; GENETIC VARIATION; HEPATITIS B; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HOMOSEXUALITY, MALE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; NETHERLANDS; PROGRAM EVALUATION;

HEPATITIS B VIRUS;

EID: 71549136520     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwp366     Document Type: Note

References (11)

1. van Ballegooijen MW, van Houdt R, Bruisten SM, et al. Molecular sequence data of hepatitis B virus and genetic diversity after vaccination. Am J Epidemiol. 2009;170(12):1455-1463.
2. Kingman JF. The coalescent. Stoch Proc Appl. 1982;13: 235-248.
3. Drummond AJ, Rambaut A, Shapiro B, et al. Bayesian co-alescent inference of past population dynamics from molecular sequences. Mol Biol Evol. 2005;22(5):1185-1192.
4. Magnius LO, Norder H. Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene. Intervirology. 1995;38(1-2): 24-34.
5. Torresi J. The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus. J Clin Virol. 2002;25(2):97-106.
6. Halloran ME, Struchiner CJ, Longini IM Jr. Study designs for different efficacy and effectiveness aspects of vaccination. Am J Epidemiol. 1997;146(10):789-803.
7. Gilbert P, Self S, Rao M, et al. Sieve analysis: methods for assessing from vaccine trial data how vaccine efficacy varies with genotypic and phenotypic pathogen variation. J Clin Epidemiol. 2001;54(1):68-85.
8. Sun Y, Gilbert PB, McKeague IW. Proportional hazards models with continuous marks. Ann Stat. 2009;37:394-426.
9. Lipsitch M. Interpreting results from trials of pneumococcal conjugate vaccines: a statistical test for detecting vaccine-induced increases in carriage of nonvaccine serotypes. Am J Epidemiol. 2000;154(1):85-92.
10. Peters TR, Poehling KA. Invasive pneumococcal disease: the target is moving. JAMA. 2007;297(16):1825-1826.
11. Rambaut A, Pybus OG, Nelson MI, et al. The genomic and epidemiological dynamics of human influenza Avirus. Nature. 2008;453(7195):615-619.